Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 256,016 | 272,990 | 299,023 | 296,767 | 301,460 |
| Cost of Goods | 46,494 | 45,901 | 49,467 | 51,877 | 49,991 |
| Gross Profit | 209,522 | 227,089 | 249,556 | 244,890 | 251,469 |
| Operating Expenses | 178,859 | 192,986 | 201,455 | 200,253 | 201,318 |
| Operating Income | 31,157 | 35,004 | 48,568 | 45,514 | 51,142 |
| Interest Expense | 10 | 12 | 9 | 8 | 9 |
| Other Income | 1,365 | 1,302 | 904 | 1,020 | 397 |
| Pre-tax Income | 32,512 | 36,294 | 49,463 | 46,526 | 51,530 |
| Income Tax | 11,134 | 12,122 | 17,132 | 15,486 | 17,623 |
| Net Income Continuous | 21,378 | 24,172 | 32,331 | 31,040 | 33,907 |
| Net Income | $21,378 | $24,172 | $32,331 | $31,040 | $33,907 |
| EPS Basic Total Ops | 0.92 | 1.03 | 1.36 | 1.28 | 1.40 |
| EPS Basic Continuous Ops | 0.92 | 1.03 | 1.35 | 1.28 | 1.40 |
| EPS Diluted Total Ops | 0.91 | 1.01 | 1.33 | 1.24 | 1.36 |
| EPS Diluted Continuous Ops | 0.91 | 1.01 | 1.32 | 1.24 | 1.37 |
| EBITDA(a) | $36,899 | $40,893 | $52,677 | $49,563 | $55,296 |